Sino Biopharmaceutical and Boehringer Ingelheim Agree Oncology Partnership
Sino Biopharmaceutical said it reached a strategic partnership with Germany’s Boehringer Ingelheim in oncology, with a potential total value of 70亿美元.
Related stories
Trom Industries Gets 32.1 Million Rupee Order From Zydus Pharmaceuticals
M impact | EQUITY | Nov 04, 2026, 10:15 AM UTC
IT City Posts Quarterly Attributable Profit of 103.8 Million Baht
M impact | EQUITY | Nov 04, 2026, 10:15 AM UTC
Atrys Health Announces Webcast for Third-Quarter Results
Atrys Health announced a webcast about its third-quarter results.
M impact | EQUITY | Nov 04, 2026, 10:15 AM UTC
Atrys Health schedules webcast for third-quarter 2026 results
Atrys Health will present its third-quarter 2026 results via webcast.
M impact | EQUITY | Nov 04, 2026, 10:15 AM UTC
Kumpulan Wang Persaraan Acquires 745,100 Dialog Group Shares
M impact | EQUITY | Nov 04, 2026, 10:14 AM UTC
Novo Nordisk CEO Says Brazil Business Is Struggling After Semaglutide Exclusivity Loss
The CEO said price is central in Brazil.
M impact | EQUITY | Nov 04, 2026, 10:14 AM UTC